Nabriva Therapeutics AG | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (15)

View All

Latest Posts

About This Stock More About This Stock
Nabriva Therapeutics Announces $20 Million Registered Direct Offering
Article By: NASDAQ GlobeNewswire
Friday, December 20, 2019 10:13 AM EDT
Nabriva Therapeutics plc today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale in a registered direct offering of an aggregate of 13,793,106 ordinary shares.
In this article: NBRV
Read
Wall Street's Top Stories At Midday, May 1st
Article By: The Fly
Wednesday, May 1, 2019 1:35 PM EDT
Stocks rise after Apple earnings beat as investors await the Fed.
In this article: CVS, HD, NUS, PCRX, AAPL, GILD, GRMN, ENPH, HRTX, TWLO, NBRV
Read
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Article By: Benzinga
Saturday, April 27, 2019 6:05 PM EDT
Biotech stocks staged a recovery this week after being in the red in the previous two weeks.
In this article: BTX, BOLD, REGN, BIIB, GWPH, ALDX, HRTX, IONS, ADAP, NBRV, BHVN, NVS, SNY, RHHBY, ABBV
Read
Week In Review: WuXi AppTec Plans $910 Million Shanghai IPO
Article By: ChinaBio® Today
Saturday, March 31, 2018 5:15 PM EDT
WuXi AppTec announced a $910 million IPO on the Shanghai exchange for the company's core small-molecule CRO business . China regulators approved WuXi's prospectus in a short seven weeks, indicating that they are very eager to list the company.
In this article: NBRV
Read
All Posts

Latest Tweets for $NBRV

No tweets yet!

PARTNER HEADLINES